Delaware
|
001-55473
|
26-4333375
|
||
(State or other jurisdiction
of incorporation) |
(Commission File Number)
|
(IRS Employer
Identification No.) |
||
8441 Wayzata Blvd., Suite 240
Minneapolis, Minnesota
|
55426
|
|
(Address of principal executive offices)
|
(Zip Code)
|
(Former name or former address, if changed since last report)
|
(1)
|
Approval of the Fifth Plan Amendment to increase the number of shares of common stock available for issuance under the Plan by 3,500,000 shares, to a total of 15,186,123 shares of common stock.
|
(2)
|
Approval of the Certificate Amendment to increase the number of authorized shares of common stock from 50,000,000 to 200,000,000 shares.
|
(1)
|
Approval of the Fifth Plan Amendment to increase the number of shares of common stock available for issuance under the Plan by 3,500,000 shares, to a total of 15,186,123 shares of common stock:
|
For
|
Against
|
Abstain
|
Broker Non-Votes
|
|||||||||||
9,323,909
|
310,546
|
60,150
|
3,039,325
|
(2)
|
Approval of the Certificate Amendment to increase the number of authorized shares of common stock from 50,000,000 to 200,000,000 shares:
|
For
|
Against
|
Abstain
|
||||||||
11,900,617
|
771,540
|
61,773
|
Exhibit Number
|
Description
|
|
3.1
|
||
10.1
|
BioSig Technologies, Inc. | |||
Date: November 25, 2016
|
By:
|
/s/ Kenneth L. Londoner | |
Name: Kenneth L. Londoner | |||
Title: Executive Chairman
|
|||